Admission Date:  [**2118-5-2**]              Discharge Date:   [**2118-5-25**]  Date of Birth:  [**2077-1-4**]             Sex:   F  Service: MEDICINE  Allergies: Latex  Attending:[**First Name3 (LF) 30**] Chief Complaint: OSH transfer with BP control issues and [**First Name3 (LF) **]  Major Surgical or Invasive Procedure: [**2118-5-4**] Fine needle aspiration of left neck mass [**2118-5-9**] Ultrasound guided thyroid biopsy [**2118-5-17**] Infraparathyroidectomy   History of Present Illness: 41 y/o F with PMH significant for HTN, obesity, R-MCA [**Month/Day/Year **] syndrome, hypercalcemia [**1-19**] parathyroid adenoma s/p parathyroidectomy [**2118-5-18**] is admitted to medicine for monitoring of electrolytes.
She was then admitted to the [**Hospital1 **] [**Hospital1 **] service where she was noted to have residual LUE weakness and L facial droop with brain MRIs pos for multiple acute foci in R frontal/parietal lobes.
Has been on Nitro gtt, Nicardipine gtt (weaned off [**5-5**]) and currently on Amlodipine 10, Labetalol 200 [**Hospital1 **], Metoprolol 5 IV prn.
IVF's and Lasix has decreased Ca to lowest level 8.1.
Thyroid u/s showed two L lobe thyroid nodules, and another nodule lateral to the thyroid gland which was FNA'd on [**2118-5-4**], with pathology showing parathyroid tissue.
Endocrinology and Endocrine surgery has been involved and she is currently POD#1 for L inferior parathyroidectomy.
ROS: She denies any fevers/chills/, nausea/vomiting, chest pain/SOB/stridor, abdominal discomfort, dysuria, edema.
Pertinent Results: Labs on admission: [**2118-5-2**] 11:12AM BLOOD WBC-11.6* RBC-4.71 Hgb-14.1 Hct-40.0 MCV-85 MCH-29.9 MCHC-35.2* RDW-14.5 Plt Ct-266 [**2118-5-2**] 11:12AM BLOOD Neuts-89.8* Lymphs-5.8* Monos-3.4 Eos-0.6 Baso-0.4 [**2118-5-2**] 11:12AM BLOOD PT-12.1 PTT-19.1* INR(PT)-1.0 [**2118-5-6**] 03:55AM BLOOD Lupus-NEG [**2118-5-6**] 03:55AM BLOOD AT-110 ProtCFn-PND ProtSFn-PND [**2118-5-6**] 03:55AM BLOOD ACA IgG-PND ACA IgM-PND [**2118-5-2**] 11:12AM BLOOD Glucose-117* UreaN-11 Creat-0.9 Na-140 K-3.8 Cl-108 HCO3-23 AnGap-13 [**2118-5-2**] 11:12AM BLOOD ALT-14 AST-20 CK(CPK)-23* AlkPhos-143* Amylase-42 TotBili-0.7 [**2118-5-2**] 11:12AM BLOOD CK-MB-2 cTropnT-0.02* [**2118-5-2**] 08:26PM BLOOD CK-MB-2 cTropnT-0.02* [**2118-5-3**] 03:25AM BLOOD CK-MB-2 cTropnT-0.02* [**2118-5-2**] 11:12AM BLOOD Albumin-4.1 Calcium-12.0* Phos-2.0* Mg-2.1 [**2118-5-10**] 06:30AM BLOOD %HbA1c-5.2 eAG-103 [**2118-5-10**] 06:30AM BLOOD Triglyc-247* HDL-36 CHOL/HD-4.0 LDLcalc-58 [**2118-5-2**] 11:12AM BLOOD TSH-1.0 [**2118-5-3**] 03:25AM BLOOD TSH-0.69 [**2118-5-2**] 12:01PM BLOOD PTH-424* [**2118-5-3**] 03:25AM BLOOD T3-119 Free T4-1.1 [**2118-5-4**] 11:47AM BLOOD PTH-DONE [**2118-5-6**] 03:55AM BLOOD b2micro-2.5* [**2118-5-2**] 11:28AM BLOOD Type-ART pH-7.47* [**2118-5-2**] 11:28AM BLOOD freeCa-1.60* [**2118-5-3**] 03:32AM BLOOD freeCa-1.48* [**2118-5-2**] 12:58PM BLOOD VITAMIN D Test                        Result               Reference Range/units VITAMIN D, 25 OH, TOTAL       12  L               30-100 ng/mL VITAMIN D, 25 OH, D3          12                  ng/mL VITAMIN D, 25 OH, D2          <4                  ng/mL [**2118-5-6**] 03:55AM BLOOD FACTOR V LEIDEN-FACTOR V LEIDEN (R506Q) MUTATION NOT DETECTED [**2118-5-6**] 03:55AM BLOOD PROTHROMBIN MUTATION ANALYSIS-THE G20210A MUTATION NOT DETECTED .
The Dobhoff tube extends to the distal stomach and possibly the duodenal bulb.
The procedure was quite difficult due to patient motion, despite attempts at head restraint, and the close proximity of the carotid and subclavian arteries.
This can be targeted for fine-needle aspiration when the patient is capable and based on the results of the FNA performed today.
The procedure was quite difficult due to patient motion, despite attempts at head restraint, and the close proximity of the carotid and subclavian arteries.
This can be targeted for fine-needle aspiration when the patient is capable and based on the results of the FNA performed today.
Consideration was given to send patient to the radiology intervention laboratory for correction of line position.
Prominent voltage in leads I and aVL with ST-T wave abnormalities.
Pathology/cytology: LEFT NECK MASS Procedure Date of [**2118-5-4**] SPECIMEN RECEIVED: [**2118-5-4**]    11-[**Numeric Identifier **]    LEFT NECK MASS SPECIMEN DESCRIPTION: Received in cytolyt  Prepared 1 ThinPrep slide CLINICAL DATA: Lt neck mass ?
SPECIMEN SUBMITTED: LEFT NECK MASS FNA FOR CELL BLOCK (C11-[**Pager number **]B) Procedure date     Tissue received     Report Date    Diagnosed by [**2118-5-4**]         [**2118-5-5**]          [**2118-5-9**]     DR. [**Last Name (STitle) **].
A cell block is made using the plasma-thrombin method and is entirely submitted in cassette A for permanent section.
Hypercoagulable work-up (Protein S Profile; Protein C Profile; Anti-Cardiolipin Antibody; Lupus Anticoagulant; Beta 2 Microglobulin; Factor V Leiden; Antithrombin functional; Prothrombin Mutation Analysis) was unrevealing and fibrinogen level was at the high end of normal.
She was started on aspirin for secondary prevention.
She was also started on simvastatin for lipid control and antihypertensives as below for blood pressure control.
She will need to continue speech, occupational, and physical therapy.
#HYPERTENSION: She was not on any anti-hypertensives as an outpatient but was noted to be hypertensive on initial presetnation and initially required nicardipine drip for BP control.
She was able to be weaned off the nicardipine drip on [**5-5**] and was started on amlodipine 10mg daily and labetalol 200mg twice daily, with adequate control in blood pressure.
General endocrine surgery performed an inferior parathyroidectomy on [**2118-5-18**].
She was started on calcium carbonate and vitamin D 1000 units daily.
She will require outpatient ENT evaluation for biopsy.
Nitroglycerine did not change the chest pressure.
It was thought to be musculoskeletal and she was started on a lidocaine patch with good effect.
#NUTRITION: Patient initially required Dobhoff for medication and aspiration risk diet.
Patient remained on ground, mechanical soft, pureed consistency, soft dysphagia solids with thin liquids during this admission.
#CONSTIPATION: She was started on a bowel regimen of colase, senna, miralax and intermittently required an enema.
#DVT PROPHYLAXIS: She was maintained on heparin 5000 TID SQ during her hospitalization.
This can be continued at rehab and then discontinued when she starts to ambulate.
Tums (?for GERD)  Discharge Medications: 1. simvastatin 10 mg Tablet Sig: One (1) Tablet PO DAILY (Daily) as needed for [**State **], 2ndary ppx.
2. aspirin 325 mg Tablet Sig: One (1) Tablet PO DAILY (Daily) as needed for [**State **] 2ndary ppx.
3. amlodipine 5 mg Tablet Sig: Two (2) Tablet PO DAILY (Daily).
4. fluoxetine 20 mg Capsule Sig: One (1) Capsule PO DAILY (Daily).
5. cholecalciferol (vitamin D3) 1,000 unit Tablet Sig: One (1) Tablet PO DAILY (Daily).
6. calcium carbonate 200 mg calcium (500 mg) Tablet, Chewable Sig: One (1) Tablet, Chewable PO BID (2 times a day).
7. lidocaine 5 %(700 mg/patch) Adhesive Patch, Medicated Sig: One (1) Adhesive Patch, Medicated Topical DAILY (Daily) as needed for pain.
8. docusate sodium 100 mg Capsule Sig: One (1) Capsule PO BID (2 times a day) as needed for constipation ppx.
9. senna 8.6 mg Tablet Sig: One (1) Tablet PO BID (2 times a day) as needed for constipation ppx.
10. polyvinyl alcohol-povidone 1.4-0.6 % Dropperette Sig: [**12-19**] Drops Ophthalmic PRN (as needed) as needed for left eye dryness.
11. polyethylene glycol 3350 17 gram/dose Powder Sig: One (1) PO DAILY (Daily).
12. heparin (porcine) 5,000 unit/mL Solution Sig: One (1) Injection TID (3 times a day): Please stop when able to ambulate.
13. acetaminophen 325 mg Tablet Sig: 1-2 Tablets PO Q6H (every 6 hours) as needed for pain.
14. bisacodyl 5 mg Tablet, Delayed Release (E.C.)
15. simethicone 80 mg Tablet, Chewable Sig: One (1) Tablet, Chewable PO TID (3 times a day) as needed for gas discomfort.
16. labetalol 100 mg Tablet Sig: Three (3) Tablet PO BID (2 times a day): hold for SBP<100.
Discharge Instructions: You were originally admitted to the [**Hospital6 **] unit for a right middle cerebral artery [**Hospital6 **].
You were started on aspirin for [**Hospital6 **] protection.
You were started on simvastatin for cholesterol control.
You were started on medication to better control your blood pressure.
You need to continue your blood pressure control.
Your calcium was found to be elevated and your parathyroid hormone was high indicating your parathyroid gland was over-secreting confirmed by imaging.
Since high levels of calcium is dangerous for your heart and increases your rate of getting a [**Name10 (NameIs) **], your parathyroid glands were removed by surgery and you were monitored for electrolyte abnormalities which were persistently normal.
